People · Operator
Named in public records as an officer, director or promoter · active 2009–2025 · Biotechnology, Other, Other Technology, Fintech, Energy / Climate
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Genocea Biosciences, Inc. | — | Biotechnology | Series C | $153.6M | $3.0B | 2019 |
| iBio, Inc. | — | Biotechnology | Series B | $74.4M | $96.3M | 2023 |
| Brazil Potash Corp. | — | Other | Series B | $29.0M | $125.3M | 2009 |
| Savi Technology, Inc. | — | Other Technology | Series B | $15.0M | $457.0M | 2015 |
| Parametrix Group Holdings, Inc. | — | Other Technology | Series A | $14.3M | $54.0M | 2023 |
| roobrik, inc. | — | Other Technology | Seed | $4.7M | $34.4M | 2018 |
| Grey, Inc. | — | Fintech | Seed | $3.0M | $24.6M | 2018 |
| Spindle, Inc. | — | Other Technology | Seed | $2.9M | $42.1M | 2015 |
| Pixion Batteries Inc. | — | Energy / Climate | Seed | $2.2M | $5.5M | 2025 |
| Deltek, Inc | — | Other Technology | Seed | $2.0M | $68.1M | 2009 |
| WeeSchool, Inc. | — | Other Technology | Seed | $1.9M | $6.8M | 2016 |
| Republic Project | — | Other | Pre-Seed | $250K | $417K | — |
William Clark at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside William Clark on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Asish Xavier | 1 | 18 |
| Ali Behbahani | 1 | 17 |
| LEON CHEN | 1 | 15 |
| Kevin Bitterman | 1 | 15 |
| Stan Bharti | 1 | 14 |
| Michael Hoffman | 1 | 11 |
| Michael Higgins | 1 | 9 |
| Simeon George | 1 | 8 |
| David Levin | 1 | 7 |
| Stephen Hoffman | 1 | 7 |
| Deborah Battiston | 1 | 6 |
| JAMES HILL | 1 | 6 |
| David Gower | 1 | 5 |
| Ryan Swagar | 1 | 5 |
| Pierre Pettigrew | 1 | 5 |
| Albert Notini | 1 | 5 |
| Katrine Bosley | 1 | 4 |
| ROBERT KAY | 1 | 4 |
| ROBERT PAULL | 1 | 4 |
| Robert Erwin | 1 | 4 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.